Farther Finance Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Farther Finance Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.8K	Sell	106 -3	-3%	-$1.54K	﹤0.01%	3146
2026 Q1	$57.8K	Sell	109 -31	-22%	-$14.8K	﹤0.01%	2892
2025 Q4	$81.5K	Buy	140 +36	+35%	+$18.4K	﹤0.01%	2475
2025 Q3	$47.7K	Buy	104 +13	+14%	+$4.85K	﹤0.01%	2464
2025 Q2	$27.5K	Sell	91 -20	-18%	-$5.96K	﹤0.01%	2475
2025 Q1	$36K	Buy	111 +99	+825%	+$32.5K	﹤0.01%	2073
2024 Q4	$3.7K	Buy	12 +4	+50%	+$1.13K	﹤0.01%	2787
2024 Q3	$1.7K	Sell	8 -3	-27%	-$767	﹤0.01%	3049
2024 Q2	$3.07K	Buy	+11	New	+$2.62K	﹤0.01%	2615

Other funds holding MDGL

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors's MDGL Position: Q2 2026 in Review

Farther Finance Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.8% in Q2 2026, selling an estimated $1.54K and leaving 106 shares worth $56.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3146.

Farther Finance Advisors first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $81.5K in Q4 2025. 34 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Farther Finance Advisors held 106 shares of Madrigal Pharmaceuticals worth $56.8K as of Q2 2026.
Farther Finance Advisors sold 3 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.54K.
Madrigal Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3146 holding.
Farther Finance Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Farther Finance Advisors's Madrigal Pharmaceuticals position peaked at $81.5K in Q4 2025.
34 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.